Celsus Therapeutics Announces Formation Of New Dermatology Scientific Advisory Board
NEW YORK and LONDON, April 7, 2014 (GLOBE NEWSWIRE) -- Celsus Therapeutics Plc (Nasdaq:CLTX), an emerging growth, development-stage biotech company, announced today the formation of a new Dermatology Scientific Advisory Board (SAB). The SAB is comprised of:
Help employers find you! Check out all the jobs and post your resume.